Silexion Therapeutics Corp (SLXN, SLXNW)

CIK 2022416 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Silexion Therapeutics Corp.

Recent SEC filings

FiledFormAccession number
Oct 28, 2026S-30001178913-26-004894
Oct 26, 20268-K0001178913-26-004849
Oct 19, 2026DEFA14A0001178913-26-004794
Oct 5, 2026DEF 14A0001178913-26-004708
Sep 30, 20268-K0001178913-26-004666
Sep 29, 2026424B30001178913-26-004647
Sep 29, 20268-K0001178913-26-004645
Sep 28, 2026SCHEDULE 13D/A0001213900-26-104066
Sep 28, 20268-K0001178913-26-004628
Sep 25, 20268-K0001178913-26-004609
Sep 25, 20268-K0001178913-26-004604
Sep 25, 2026PRE 14A0001178913-26-004606
Sep 16, 2026DEFA14A0001178913-26-004531
Sep 9, 2026DEFA14A0001178913-26-004466
Aug 24, 2026DEF 14A0001178913-26-004243
Aug 21, 20268-K0001178913-26-004223
Aug 19, 2026SCHEDULE 13D/A0001213900-26-091845
Aug 18, 2026SCHEDULE 13G0001213900-26-091333
Aug 14, 202610-Q0001178913-26-004138
Aug 14, 20268-K0001178913-26-004136
Aug 14, 2026PRE 14A0001178913-26-004145
Aug 13, 20268-K0001178913-26-004128
Aug 13, 2026SCHEDULE 13G/A0001213900-26-088835
Aug 13, 20268-K0001178913-26-004122
Aug 13, 2026424B40001178913-26-004116